1.0200
0.0000
(0.00%)
As of 9:17:15 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-91,564
-94,751
-116,046
-102,139
-77,590
Financing Cash Flow
55,647
62,658
-779
112,598
176,301
End Cash Position
67,278
54,186
83,741
201,008
188,605
Issuance of Capital Stock
--
64,500
--
113,767
177,614
Repurchase of Capital Stock
--
--
-111
--
--
Free Cash Flow
-91,564
-94,751
-116,046
-102,139
-77,590
12/31/2021 - 8/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2X10.DU Abivax SA
5.30
+2.91%
2I9.F Karolinska Development AB (publ)
0.0641
+2.40%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
5IU.F Isofol Medical AB (publ)
0.1469
-2.07%
6JU0.F BioCardia, Inc.
0.0000
-100.00%
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
6DW.F D. Western Therapeutics Institute, Inc.
0.5750
+3.60%
2DE0.F Genprex, Inc.
0.0000
-100.00%
2KZ0.F Kezar Life Sciences, Inc.
3.5000
-1.69%